vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $270.6M, roughly 1.0× Astera Labs, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 0.7%, a 15.9% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs -16.5%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $3.4M).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
ALAB vs HCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $270.8M |
| Net Profit | $45.0M | $2.0M |
| Gross Margin | 75.6% | 37.7% |
| Operating Margin | 24.7% | -13.2% |
| Net Margin | 16.6% | 0.7% |
| Revenue YoY | 91.8% | -16.5% |
| Net Profit YoY | 82.0% | -83.6% |
| EPS (diluted) | $0.25 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | $270.8M | ||
| Q3 25 | $230.6M | — | ||
| Q2 25 | $191.9M | $277.7M | ||
| Q1 25 | $159.4M | $324.5M | ||
| Q4 24 | $141.1M | — | ||
| Q3 24 | $113.1M | — | ||
| Q2 24 | $76.8M | $305.7M | ||
| Q1 24 | $65.3M | — |
| Q4 25 | $45.0M | $2.0M | ||
| Q3 25 | $91.1M | — | ||
| Q2 25 | $51.2M | $455.0M | ||
| Q1 25 | $31.8M | $11.9M | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $-7.6M | — | ||
| Q2 24 | $-7.5M | $25.8M | ||
| Q1 24 | $-93.0M | — |
| Q4 25 | 75.6% | 37.7% | ||
| Q3 25 | 76.2% | — | ||
| Q2 25 | 75.8% | 0.1% | ||
| Q1 25 | 74.9% | 48.0% | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 77.7% | — | ||
| Q2 24 | 77.9% | 41.1% | ||
| Q1 24 | 77.4% | — |
| Q4 25 | 24.7% | -13.2% | ||
| Q3 25 | 24.0% | — | ||
| Q2 25 | 20.7% | -1.3% | ||
| Q1 25 | 7.1% | -5.0% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | -7.9% | — | ||
| Q2 24 | -31.7% | -9.0% | ||
| Q1 24 | -127.1% | — |
| Q4 25 | 16.6% | 0.7% | ||
| Q3 25 | 39.5% | — | ||
| Q2 25 | 26.7% | 163.8% | ||
| Q1 25 | 20.0% | 3.7% | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | -6.7% | — | ||
| Q2 24 | -9.8% | 8.4% | ||
| Q1 24 | -142.5% | — |
| Q4 25 | $0.25 | $0.00 | ||
| Q3 25 | $0.50 | — | ||
| Q2 25 | $0.29 | $0.52 | ||
| Q1 25 | $0.18 | $0.01 | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.05 | $0.03 | ||
| Q1 24 | $-1.77 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $1.4B | $1.2B |
| Total Assets | $1.5B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $1.4B | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $162.3M | $1.4B | ||
| Q1 25 | $86.4M | $836.1M | ||
| Q4 24 | $79.6M | — | ||
| Q3 24 | $126.1M | — | ||
| Q2 24 | $421.1M | $802.5M | ||
| Q1 24 | $696.1M | — |
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M | ||
| Q1 24 | — | — |
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.0B | $759.9M | ||
| Q4 24 | $964.8M | — | ||
| Q3 24 | $889.6M | — | ||
| Q2 24 | $845.3M | $740.1M | ||
| Q1 24 | $808.8M | — |
| Q4 25 | $1.5B | $1.8B | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.3B | $1.8B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $983.1M | — | ||
| Q2 24 | $915.5M | $1.3B | ||
| Q1 24 | $864.9M | — |
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $8.2M |
| Free Cash FlowOCF − Capex | $76.6M | $3.4M |
| FCF MarginFCF / Revenue | 28.3% | 1.2% |
| Capex IntensityCapex / Revenue | 6.9% | 1.8% |
| Cash ConversionOCF / Net Profit | 2.12× | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $8.2M | ||
| Q3 25 | $78.2M | — | ||
| Q2 25 | $135.4M | $-72.9M | ||
| Q1 25 | $10.5M | $40.3M | ||
| Q4 24 | $39.7M | — | ||
| Q3 24 | $63.5M | — | ||
| Q2 24 | $29.8M | $-39.8M | ||
| Q1 24 | $3.7M | — |
| Q4 25 | $76.6M | $3.4M | ||
| Q3 25 | $65.9M | — | ||
| Q2 25 | $133.3M | $-82.2M | ||
| Q1 25 | $6.0M | $32.5M | ||
| Q4 24 | $24.3M | — | ||
| Q3 24 | $46.8M | — | ||
| Q2 24 | $28.5M | $-49.9M | ||
| Q1 24 | $228.0K | — |
| Q4 25 | 28.3% | 1.2% | ||
| Q3 25 | 28.6% | — | ||
| Q2 25 | 69.5% | -29.6% | ||
| Q1 25 | 3.7% | 10.0% | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 41.4% | — | ||
| Q2 24 | 37.1% | -16.3% | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 6.9% | 1.8% | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 1.1% | 3.3% | ||
| Q1 25 | 2.8% | 2.4% | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 14.8% | — | ||
| Q2 24 | 1.7% | 3.3% | ||
| Q1 24 | 5.2% | — |
| Q4 25 | 2.12× | 4.21× | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 2.64× | -0.16× | ||
| Q1 25 | 0.33× | 3.38× | ||
| Q4 24 | 1.61× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.54× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
